HOUSTON (AP) _ Salarius Pharmaceuticals, Inc. (SLRX) on Wednesday reported a loss of $1.9 million in its first quarter.
On a per-share basis, the Houston-based company said it had a loss of 6 cents.
The biotech drug developer posted revenue of $1.3 million in the period.
The company's shares closed at $1.08. A year ago, they were trading at $1.75.
The Associated Press